产品中心-北京博奥森生物技术有限公司

产品编号	BIO0911SM
英文名称	Anti-human TNFSF7 / CD27L / CD70 (Vorsetuzumab mafodotin Biosimilar)
中文名称
抗体来源
克隆类型	Monoclonal
克隆号
交叉反应	Human
产品应用	not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
理论分子量	146.1 kDa
检测分子量
性状	Lyophilized
亚型	Human IgG1
纯化方法	Protein A
保存条件	For long term storage, the produce should be stored at -20°C or lower.
注意事项	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed	PubMed
产品介绍
产品图片	Human TNFSF7 / CD27L / CD70 CHO-K1 Cell Line were stained with Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS,The EC50 is 0.11_x000D_ μg/mL. Immobilized humanCD70-His at 2 ug/mL (30 μL/well) can bind Anti-TNFSF7 / CD27L / CD70 Reference Antibody (Vorsetuzumab mafodotin) with the EC50 of 0.007612 ug/mL. The drug-to-antibody ratio (DAR) of the Anti-TNFSF7 / CD27L / CD70 Reference Antibody (Vorsetuzumab mafodotin) is 3.8. The purity of Anti-TNFSF7 / CD27L / CD70 Reference Antibody (Vorsetuzumab mafodotin) is 99.29%, determined by SEC-HPLC.